Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ELDER PHARMA vs PFIZER - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ELDER PHARMA PFIZER ELDER PHARMA/
PFIZER
 
P/E (TTM) x -1.0 38.2 - View Chart
P/BV x 0.1 6.0 1.7% View Chart
Dividend Yield % 0.0 1.7 -  

Financials

 ELDER PHARMA   PFIZER
EQUITY SHARE DATA
    ELDER PHARMA
Jun-14
PFIZER
Mar-23
ELDER PHARMA/
PFIZER
5-Yr Chart
Click to enlarge
High Rs3804,662 8.2%   
Low Rs1883,407 5.5%   
Sales per share (Unadj.) Rs489.2530.0 92.3%  
Earnings per share (Unadj.) Rs-3.2136.4 -2.3%  
Cash flow per share (Unadj.) Rs14.4159.4 9.0%  
Dividends per share (Unadj.) Rs070.00 0.0%  
Avg Dividend yield %01.7 0.0%  
Book value per share (Unadj.) Rs376.5701.0 53.7%  
Shares outstanding (eoy) m20.5445.75 44.9%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.67.6 7.6%   
Avg P/E ratio x-89.329.6 -301.9%  
P/CF ratio (eoy) x19.725.3 77.9%  
Price / Book Value ratio x0.85.8 13.1%  
Dividend payout %051.3 -0.0%   
Avg Mkt Cap Rs m5,832184,576 3.2%   
No. of employees `000NANA-   
Total wages/salary Rs m2,1793,317 65.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m10,04824,248 41.4%  
Other income Rs m2571,011 25.4%   
Total revenues Rs m10,30525,258 40.8%   
Gross profit Rs m2,9218,420 34.7%  
Depreciation Rs m3611,055 34.2%   
Interest Rs m2,756135 2,044.7%   
Profit before tax Rs m608,240 0.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1252,001 6.3%   
Profit after tax Rs m-656,239 -1.0%  
Gross profit margin %29.134.7 83.7%  
Effective tax rate %209.124.3 861.3%   
Net profit margin %-0.625.7 -2.5%  
BALANCE SHEET DATA
Current assets Rs m9,24024,933 37.1%   
Current liabilities Rs m9,9986,574 152.1%   
Net working cap to sales %-7.575.7 -10.0%  
Current ratio x0.93.8 24.4%  
Inventory Days Days12893 137.3%  
Debtors Days Days6022 26,350.0%  
Net fixed assets Rs m13,64213,780 99.0%   
Share capital Rs m206458 45.0%   
"Free" reserves Rs m7,52831,616 23.8%   
Net worth Rs m7,73332,073 24.1%   
Long term debt Rs m4,8890-   
Total assets Rs m22,88239,031 58.6%  
Interest coverage x1.062.1 1.6%   
Debt to equity ratio x0.60-  
Sales to assets ratio x0.40.6 70.7%   
Return on assets %11.816.3 72.0%  
Return on equity %-0.819.5 -4.3%  
Return on capital %22.326.1 85.4%  
Exports to sales %3.12.8 107.6%   
Imports to sales %0.40 1,238.3%   
Exports (fob) Rs m307688 44.6%   
Imports (cif) Rs m438 513.1%   
Fx inflow Rs m307688 44.6%   
Fx outflow Rs m1258 1,491.3%   
Net fx Rs m181679 26.7%   
CASH FLOW
From Operations Rs m11,7543,557 330.5%  
From Investments Rs m-561-361 155.5%  
From Financial Activity Rs m-6,762-3,458 195.5%  
Net Cashflow Rs m5,466-262 -2,089.5%  

Share Holding

Indian Promoters % 25.3 0.0 -  
Foreign collaborators % 0.0 63.9 -  
Indian inst/Mut Fund % 24.0 18.2 131.9%  
FIIs % 0.0 3.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 74.7 36.1 206.9%  
Shareholders   31,548 112,456 28.1%  
Pledged promoter(s) holding % 77.6 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ELDER PHARMA With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Elder Pharma vs Pfizer

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Elder Pharma vs Pfizer Share Price Performance

Period Elder Pharma Pfizer S&P BSE HEALTHCARE
1-Day 4.97% -4.83% 1.18%
1-Month 21.21% -8.27% -0.75%
1-Year -64.54% 21.74% 61.82%
3-Year CAGR -51.65% -2.08% 18.16%
5-Year CAGR -37.46% 4.94% 19.79%

* Compound Annual Growth Rate

Here are more details on the Elder Pharma share price and the Pfizer share price.

Moving on to shareholding structures...

The promoters of Elder Pharma hold a 25.3% stake in the company. In case of Pfizer the stake stands at 63.9%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Elder Pharma and the shareholding pattern of Pfizer.

Finally, a word on dividends...

In the most recent financial year, Elder Pharma paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

Pfizer paid Rs 70.0, and its dividend payout ratio stood at 51.3%.

You may visit here to review the dividend history of Elder Pharma, and the dividend history of Pfizer.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.